A clinical trial could validate the use of calcitriol, the active form of vitamin D, to treat Friedreich's Ataxia, as proposed by the Biochemistry of Oxidative Stress Group at the Biomedical Research Institute of Lleida (IRBLleida) and the University of Lleida (UdL). Their research is the basis of this trial to be carried out by the Ataxia Unit of the Josep Trueta Hospital in Girona and the Santa Caterina Hospital of the Parc Hospitalari Martà i Julià de Salt in conjunction with the Institute for Research in Biomedicine of Girona (IDIBGI).
Tuesday, June 8, 2021
A clinical trial with calcitriol has begun to validate its therapeutic potential for treating Friedreich's Ataxia
Biotech-spain.com; 07/06/2021
